Skip to content
All
  • All
  • Andy Cole Fund
  • Blog
  • Collaboration and partnerships
  • Coronavirus
  • Corporate partnership
  • Fundraising
  • Health Equalities
  • Kidneyversary
  • Patient Stories
  • Podcast
  • Research
  • Uncategorised
  • Volunteering
Professor David Long in the research lab

Improving outcomes for patients born with posterior urethral valves

Professor David Long and his team at University College London are looking to improve outcomes for patients born with posterior urethral valves (PUV). In PUV the bladder can change and become less flexible. This affects the way urine can flow out of the body, increasing the risk of developing chronic kidney disease (CKD) and kidney…

Pamela Scarborough, Beam Co-Founder

Kidney-BEAM for kids

Dr Pelagia Koufaki and her team are looking to replicate the enormous success of the Kidney-BEAM platform by creating a bespoke version of the portal for children and young people with chronic kidney disease (CKD). Kidney Research UK are delighted to support this work after having funded Kidney-BEAM. The unique combination of live and on-demand…

Dr Carl May

Funding new paediatric research with your support

In our continuing commitment to identify and fund the very best research into discovering the causes of and effective treatments for kidney disease, Kidney Research UK has recently granted five new awards amounting to a total of £631,183.  Prof David Long in the research lab Professor David Long, University College London  We have awarded a…

Professor Colin A Johnson

Looking for novel treatments for autosomal dominant polycystic kidney disease

We are delighted to fund Professor Colin A Johnson and his work looking for novel treatments for autosomal dominant polycystic kidney disease (ADPKD).    The problem ADPKD is a genetic disorder that leads to fluid filled sacs (cysts) forming in the kidneys. It affects 70,000 people in the UK and up to 12 million people worldwide.…

ADPKD

Testing new treatments for autosomal dominant polycystic kidney disease

It is with great pleasure we announce that we are funding Professor Albert Ong, from the University of Sheffield, on his mission to discover and test new treatments for autosomal dominant polycystic kidney disease (ADPKD).   The problem Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disease and affects 70,000 people…

Pregnancy bump

PKD PhD Studentship for Dr Joe Cockburn

We are thrilled to fund a PhD student to work on this project under the supervision of Dr Joe Cockburn. Joe will lead a journey of discovery through faults in the PKHD1 gene and will learn more about the impact they have on the developing kidney in ARPKD, the rare form of PKD. Mutation, mutation,…

Dr Rona Smith with a patient

Trial to see if a tapeworm drug can protect vulnerable patients from Covid-19 expanded into India

PROTECT-V, a clinical trial which we helped to fund in its initial stages to find out whether a drug usually used to treat tapeworms can prevent Covid-19 infection in vulnerable kidney patients, has now expanded to India.  Protecting kidney patients from Covid-19 Despite the successful roll out of vaccinations against Covid-19 in the UK, many…

blood-cells

New treatment recommended for kidney patients with anaemia

The National Institute for Health and Care Excellence (NICE) has recommended roxadustat for the treatment of anaemia in adult chronic kidney disease (CKD) patients. The new first of its kind medication (brand name Evrenzo) will offer a simplified and more tolerable treatment. The exciting development can be traced back to original work by a former…

Paul Cookson

NICE decision brings transplant hope to highly sensitised patients

Kidney Research UK has welcomed a decision by the National Institute for Health and Care Excellence to recommend a treatment to enable people who are highly sensitised to have a kidney transplant without the organ being rejected. What is imlifidase? The new treatment, imlifidase, is produced by Hansa Biopharma who estimated there are over 100…

In the lab at the Alport Research Hub

‘Gold standard’ research hub gets to work after Manchester launch

A new research hub dedicated to the study of Alport syndrome has been launched at the University of Manchester. The Stoneygate and Kidney Research UK Alport Research Hub, was created thanks to £2.55M investment from Stoneygate Trust in partnership with charity Kidney Research UK.   As well as centres across the UK, the Hub will…

Scroll To Top